From Nerve Development To Vision A Bumpy Ride – Dr Mary Whitman, Boston Children’s Hospital
Original Article Reference
This SciPod is a summary of
https://doi.org/10.33548/SCIENTIA559
Share Episode
About this episode
The eye movement disorders strabismus (characterised by eye misalignment) and nystagmus (characterised by involuntary oscillation of the eyes) together affect up to 5% of the population and have a detrimental impact on vision. These disorders also impact on facial appearance and social interaction, which may, in turn, lead to psychological difficulties. Dr Mary Whitman, at the Boston Children’s Hospital, USA, is working to understand the genetic causes and neurological mechanisms underlying eye movement disorders to improve treatment and, ultimately, prevent their onset.
This work is licensed under a Creative Commons Attribution 4.0 International License. 
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
More episodes
Pulque: The Ancient Drink That Could Shape the Future of Health
Pulque, an ancient Mexican beverage, is making waves in the scientific community—not just as a cultural relic, but as a potential health-boosting powerhouse. A team of researchers, including Prof. Rogelio Valadez-Blanco, Dr. Yesica Ruiz-Ramírez, and Prof. Paula Guadarrama-Mendoza, from Universidad Tecnológica de La Mixteca, has been investigating the hidden potential of the bacteria found in this traditional drink. Their findings suggest that pulque’s naturally occurring lactic acid bacteria could play a key role in promoting gut health and even combating harmful pathogens that cause foodborne illnesses.
Lixiang Zhang | Seeing the Full Picture: The CPS-Merge Approach to Assess Complex Datasets
In the age of big data, and particularly in specialisations such as artificial intelligence, biology, and medicine, researchers often generate large and complex datasets that are challenging to analyse. This is particularly true for multi-view data, otherwise known as multimodal data, which are data that encompass multiple perspectives concerning a single entity or phenomenon. In the case of single-cell genomics, for instance, researchers can measure a huge range of different characteristics concerning an individual cell, such as RNA expression levels or protein levels. While multi-view datasets provide vast amounts of information, they are difficult to analyse because looking at each type of data within them provides only a small part of the overall picture. A new computational approach called Covering Point Set-merge analysis, or CPS-merge analysis for short, has been developed by Lixiang Zhang of Pennsylvania State University and colleagues, and it aims to assist researchers to merge the different types of data present in multi-view datasets into one coherent and meaningful set of results, without misrepresenting the individual contributions of each type of data.
Dr. Robert Kass | Beating arrhythmias with a heart in a dish
In the future, doctors will be able to create tiny replicas of your tissues in the lab, and then test them against a range of drugs, revealing exactly which treatments would work best for you before you even visit a drug store. This future of personalised medicine is driven by researchers such as Dr. Robert Kass of the Columbia University Medical Center. Kass and colleagues have pioneered the use of stem cells to develop personalized treatments for a genetic heart condition that disrupts normal heart rhythms. The researchers reprogrammed a patient’s skin cells into stem cells called induced pluripotent stem cells (or iPSCs for short), and they then induced the iPSCs to turn into heart cells. This allowed the research team to study how genetic mutations in the resulting heart cells affect the heart’s ion channels. Their research revealed that a mutation in a specific sodium channel was causing dangerous heart rhythms and that combining the drug mexiletine with a pacemaker device to increase heart rate, provided an effective and personalised treatment.
Dr James E. Goldman | Dr Osama Al-Dalahmah – Confronting the Challenge of Huntington Disease
Huntington disease (HD) is an inherited and progressive neurological disorder which is currently fatal. Dr James E. Goldman and Dr Osama Al-Dalahmah, both at Columbia University, USA, are utilising new techniques in molecular biology to better understand the brain pathology associated with HD. Their vision is to develop therapeutics that can slow the progression of the disease, and ultimately, treat and even prevent it.
Increase the impact of your research
• Good science communication encourages everyday people to be scientifically literate so that they can analyse the integrity and legitimacy of information.
• Good science communication encourages people into STEM-related fields of study and employment.
• Good public science communication fosters a community around research that includes both members of the public, policymakers and scientists.
• In a recent survey, 75% of people suggested they would prefer to listen to an interesting story than read it.
Step 2 SciPod script written
Step 3 Voice audio recorded
Step 4 SciPod published